| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.4M | -73.1% |
| SG&A Expense | $10.5M | -17.2% |
| Operating Income | -$22.3M | +44.2% |
| Pre-tax Income | -$21.4M | +44.2% |
| Income Tax | $41K | — |
| Net Income | -$21.4M | +44.1% |
| EPS (Basic) | -$18.53 | -1186.8% |
| EPS (Diluted) | -$18.53 | -1186.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.2M | -34.0% |
| Short-term Investments | $11.7M | +0.0% |
| Current Assets | $16.8M | -54.2% |
| Total Assets | $17.1M | -55.2% |
| Current Liabilities | $1.2M | -79.5% |
| Total Liabilities | $1.3M | -77.9% |
| Stockholders' Equity | $15.8M | -51.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.6M | +49.5% |
| Investing Cash Flow | $11.7M | -47.8% |
| Financing Cash Flow | $2.9M | +0.0% |